Kinase inhibitor
AssigneeNissan Chemical Corporation
InventorsTaito NISHINO, Keiichiro OTSUKA, Natsuki FUKASAWA, Hiroyuki NAKAJIMA, Ayako AIHARA
Life of this patent
Estimating the term…
Loading patent…
AssigneeNissan Chemical Corporation
InventorsTaito NISHINO, Keiichiro OTSUKA, Natsuki FUKASAWA, Hiroyuki NAKAJIMA, Ayako AIHARA
Estimating the term…
The present invention aims to provide a novel kinase inhibitor and the like, and a therapeutic agent for a disease, a drug discovery screening method and the like utilizing such inhibitor and the like. The compound represented by the following formula (I) and a salt thereof can inhibit plural kinases including LATS (particularly LATS2) which is the major kinase in the Hippo signal transduction pathway. In addition, diseases or tissue damage associated with failure of cellular proliferation can be treated. Therefore, the present invention is beneficial, for example, in the research field of cell functions and diseases, in which the Hippo signal transduction pathway is involved, and the like. Furthermore, it is beneficial in the medical field for the treatment of such diseases and the like. wherein each symbol is as defined in the DESCRIPTION.
A kinase inhibitor comprising a compound represented by the following formula (I), or a salt thereof:
A Hippo signal transduction pathway inhibitor comprising a compound represented by the following formula (I) or a salt thereof:
A therapeutic agent for a disease or tissue damage associated with failure of cellular proliferation, comprising a compound represented by the following formula (I) or a salt thereof:
A proliferation promoter of a cell or tissue for a transplantation treatment, comprising a compound represented by the following formula (I) or a salt thereof:
A method for screening for a substance for treating and/or preventing a disease associated with promoted nuclear translocation of YAP and/or TAZ, comprising the following steps:
An optically active form of a compound represented by the following formula (I), or a salt thereof:
Dependencies are inferred from the claim text.